• 中国科技论文统计源期刊（中国科技核心期刊）
  • 中国医药卫生核心期刊
  • 中国抗癌协会系列期刊
中国胸部肿瘤研究协作组（CTONG）
Advanced Search

Post-Operation Adjuvant Therapy of ALK Fusion Mutation in Patients With Non-small Cell Lung Cancer: Result of ALINA Study
CHEN Su, YANG Yi
2024, 24(2): 65-65. DOI: 10.12019/j.issn.1671-5144.202405003
Abstract PDF
A Milestone of Early ALK Fusion Mutation in Patients With Non-Small Cell Lung Cancer
CHEN Su, YANG Yi
2024, 24(2): 66-69. DOI: 10.12019/j.issn.1671-5144.202403017
Abstract PDF
Make it Perfect: The Future Is Coming， The Era of Postoperative Adjuvant Targeting of Rare Genetic Changes May Have Arrived
WANG Wen-jing, XU Xiao-ling, MAO Wei-min
2024, 24(2): 70-72. DOI: 10.12019/j.issn.1671-5144.202403034
Abstract PDF
The Relationship Between the Serum Dopamine, 5-Hydroxytryptamine, and Anxiety and Depression Status in Patients With Breast Cancer Undergoing Chemotherapy
LI Xiao-yan, SUN Qin, CHEN Fang
2024, 24(2): 73-77. DOI: 10.12019/j.issn.1671-5144.202103050
Abstract PDF
Study on the Correlation Between the Amount of Bacteria in the Alveolar Lavage Fluid of Children With Refractory Mycoplasma Pneumoniae Pneumonia and the Immune Response of Th1/Th2 Cells
WANG Hui-ying, TANG Yu, DONG Li-li, WANG Jing
2024, 24(2): 78-83. DOI: 10.12019/j.issn.1671-5144.202110041
Abstract PDF
Clinicopathological Analysis of Three Cases of Sinonasal Teratocarcinosarcoma and Literature Review
WU Hui-qian, LIU Yan-ping, ZHOU Ai-jun, LI Jian-ming
2024, 24(2): 84-89. DOI: 10.12019/j.issn.1671-5144.202310010
Abstract PDF
Preliminary Exploration of Simple BH3 Profiling in Screening Drug Susceptibility of Blood Tumors
ZENG Ling-ji, LI Min-ming, WANG Yu-lian, WU Miao, HUANG Yan-yan, GENG Su-xia, LAI Pei-long, DU Xin, WENG Jian-yu
2024, 24(2): 90-96. DOI: 10.12019/j.issn.1671-5144.202311009
Abstract PDF
Current Situation Investigation of Clinical Diagnosis and Treatment of Non-Small Cell Lung Cancer With MET Alterations in China
GAN Bin, LIU Si-yang, YAN Hong-hong, WU Yi-long
2024, 24(2): 97-106. DOI: 10.12019/j.issn.1671-5144.202401019
Abstract PDF
Prediction and Prognosis Analysis for Immunotherapy of Intra-tumoral Chemokines CCR1, CXCR6, and CXCL9 in Advanced Lung Adenocarcinoma
ZHONG Si-min, ZHANG Dong-dong, LI Yang-qiu, WU Yi-long, LIU Si-yang, JIN Zhen-yi
2024, 24(2): 107-114. DOI: 10.12019/j.issn.1671-5144.202402013
Abstract PDF
The Effect of NPL4-Targeted Inhibitor Disulfiram on the Expression of Genes Related to the Ubiquitin-Proteasome Pathway in T-Cell Malignancies
CAI Qing-hua, WANG Cai-xia, CHEN Cun-te
2024, 24(2): 115-123. DOI: 10.12019/j.issn.1671-5144.202404028
Abstract PDF
Current Status and Improvement Strategies of Medical Experimental Technician Team Building in Hospital Public Laboratory
YAN Wen-qing, CHEN Yu, ZHANG Xu-chao
2024, 24(2): 124-128. DOI: 10.12019/j.issn.1671-5144.202312018
Abstract PDF

Copyright © 2024 Journal of Evidence-Based Medicine粤ICP备15000268号

Address：Editorial Office of Evidence-based Medicine, Guangdong Provincial People's Hospital, No.123, Huifuxi Road, Guangzhou 510180, China，Tel：020-83844620，E-mail：xzyxzz@163.net